tiprankstipranks
Trending News
More News >
Olympus (OLYMY)
OTHER OTC:OLYMY
US Market

Olympus (OLYMY) Earnings Dates, Call Summary & Reports

Compare
34 Followers

Earnings Data

Report Date
Aug 12, 2026
TBA (Confirmed)
Period Ending
2027 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0.05
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2026
Earnings Call Date:Feb 13, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balanced significant near-term operational and regulatory challenges (FDA observations, product ship holds, one-off gross margin/COGS impacts, and increased restructuring provisioning) against clear signs of stabilization and management actions (China recovery, majority of products released, leadership changes, disciplined commercial remediation and maintained mid-term targets). Management emphasized these are addressable, one-off or execution-related issues and reiterated long-term margin and growth ambitions, but material short-term impacts keep the tone cautious.
Company Guidance
Management revised constant‑currency revenue guidance down ~2% and framed near‑term outlook as a range (reflecting the dynamic timing of product releases), while reaffirming its midterm targets of mid‑single‑digit revenue growth and a 20%+ operating margin; key metrics called out included the company’s “3–4–5” mid‑range modeling with 100+ basis points of margin improvement annually from FY27, inspections at 8 facilities (U.S., Europe, Japan) with ~70% of ship‑hold products already released and ~30% still being remediated, an expected Q4 revenue impact from ship holds of about JPY 18 billion, structural‑reform costs provisioned at JPY 31 billion (revised up from JPY 12 billion) with ~90% booked this fiscal year and the previously announced JPY 24 billion reduction effect unchanged, China showing a recovery (management cited roughly 6% Q3 growth and expects mid‑single‑digit market growth), and that one‑time COGS pressure from disposals/field corrective actions drove the gross‑margin hit rather than a fundamental mix shift.
China: Early Signs of Recovery
After several quarters of double-digit declines, China showed a turnaround with approximately 5–6% growth quarter-over-quarter following tightened go-to-market focus, local investments and weekly pipeline oversight.
Majority of Ship-Held Products Returned to Market
Management reported that ~70% of products placed on ship hold have been released back into markets after patient-safety reviews; ~30% remain under remediation.
Mid-term Plan and Margin Commitment Intact
Management reiterated the midterm '3,4,5' plan and the target of >100 basis points of annual margin improvement beginning FY27, maintaining the longer-term goal of mid-single-digit revenue growth and 20%+ operating margin.
Leadership Actions to Drive Execution
New senior appointments (new President of China Rosa Chen, global operations lead David Shan, and continued CTO leadership) aimed at strengthening go-to-market execution, operations and R&D; management emphasized building Japanese leadership depth as well.
Commercial Execution Plan for U.S. GI
Management identified U.S. GI underperformance as an execution/pipeline conversion issue (not a competitiveness problem) and outlined disciplined pipeline management and oversight actions to restore growth, expressing confidence in returning to growth in Q4.
Guidance Presented Transparently as Ranges
Company moved to range-based guidance to reflect dynamic factors (product releases timing, pipeline conversion) and stated ranges do not assume additional ship holds.

Olympus (OLYMY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OLYMY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2027 (Q1)
- / -
0.054
Feb 13, 2026
2026 (Q3)
0.15 / 0.08
0.16-47.50% (-0.08)
Nov 07, 2025
2026 (Q2)
0.14 / 0.12
0.193-39.38% (-0.08)
Aug 08, 2025
2026 (Q1)
0.11 / 0.05
0.085-36.47% (-0.03)
May 13, 2025
2025 (Q4)
0.16 / 0.25
0.078220.51% (+0.17)
Feb 14, 2025
2025 (Q3)
0.23 / 0.16
0.11835.59% (+0.04)
Nov 08, 2024
2025 (Q2)
0.21 / 0.19
-0.119262.18% (+0.31)
Aug 07, 2024
2025 (Q1)
0.09 / 0.09
1.329-93.60% (-1.24)
May 10, 2024
2024 (Q4)
0.10 / 0.08
0.187-58.29% (-0.11)
Feb 14, 2024
2024 (Q3)
0.16 / 0.12
0.246-52.03% (-0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

OLYMY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 13, 2026
$12.80$12.10-5.50%
Nov 07, 2025
$12.02$12.22+1.70%
Aug 08, 2025
$12.14$12.34+1.62%
May 13, 2025
$13.63$13.64+0.05%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Olympus (OLYMY) report earnings?
Olympus (OLYMY) is schdueled to report earning on Aug 12, 2026, TBA (Confirmed).
    What is Olympus (OLYMY) earnings time?
    Olympus (OLYMY) earnings time is at Aug 12, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OLYMY EPS forecast?
          Currently, no data Available